Nuveen Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $18.7M | Buy |
221,202
+119,780
| +118% | +$10.1M | 0.01% | 1228 |
|
2024
Q3 | $9.11M | Sell |
101,422
-1,223
| -1% | -$110K | ﹤0.01% | 1664 |
|
2024
Q2 | $8.26M | Sell |
102,645
-142,882
| -58% | -$11.5M | ﹤0.01% | 1699 |
|
2024
Q1 | $19.6M | Buy |
245,527
+10,881
| +5% | +$868K | 0.01% | 1195 |
|
2023
Q4 | $18.7M | Buy |
234,646
+18,089
| +8% | +$1.44M | 0.01% | 1206 |
|
2023
Q3 | $15.1M | Buy |
216,557
+115,342
| +114% | +$8.06M | 0.01% | 1217 |
|
2023
Q2 | $7.27M | Sell |
101,215
-13,307
| -12% | -$956K | ﹤0.01% | 1687 |
|
2023
Q1 | $7.06M | Sell |
114,522
-7,423
| -6% | -$458K | ﹤0.01% | 1692 |
|
2022
Q4 | $9.41M | Sell |
121,945
-571,579
| -82% | -$44.1M | ﹤0.01% | 1535 |
|
2022
Q3 | $30.9M | Sell |
693,524
-77,473
| -10% | -$3.46M | 0.01% | 746 |
|
2022
Q2 | $29.5M | Buy |
770,997
+348,317
| +82% | +$13.3M | 0.01% | 792 |
|
2022
Q1 | $14.1M | Sell |
422,680
-71,526
| -14% | -$2.38M | ﹤0.01% | 1418 |
|
2021
Q4 | $18.7M | Buy |
494,206
+2,949
| +0.6% | +$111K | 0.01% | 1271 |
|
2021
Q3 | $14.6M | Sell |
491,257
-167,077
| -25% | -$4.97M | ﹤0.01% | 1498 |
|
2021
Q2 | $44.4M | Buy |
658,334
+159,584
| +32% | +$10.8M | 0.01% | 814 |
|
2021
Q1 | $28.2M | Sell |
498,750
-8,433
| -2% | -$477K | 0.01% | 1065 |
|
2020
Q4 | $41.3M | Sell |
507,183
-24,372
| -5% | -$1.99M | 0.01% | 805 |
|
2020
Q3 | $37.9M | Buy |
531,555
+314,466
| +145% | +$22.4M | 0.01% | 692 |
|
2020
Q2 | $17.9M | Buy |
217,089
+35,913
| +20% | +$2.96M | 0.01% | 1119 |
|
2020
Q1 | $10.7M | Buy |
181,176
+80,000
| +79% | +$4.71M | 0.01% | 1254 |
|
2019
Q4 | $10.5M | Sell |
101,176
-2,383
| -2% | -$246K | ﹤0.01% | 1566 |
|
2019
Q3 | $2.1M | Buy |
103,559
+5,837
| +6% | +$118K | ﹤0.01% | 2372 |
|
2019
Q2 | $2.52M | Buy |
+97,722
| New | +$2.52M | ﹤0.01% | 2322 |
|